Obesity
-
techNovo Nordisk Taps OpenAI for Accelerated Drug Discovery
Novo Nordisk partners with OpenAI to leverage advanced AI, aiming to speed up drug research, improve manufacturing, and bring new treatments for obesity and diabetes to patients faster.
-
healthVML's 2026 Healthcare Trends: Precision Medicine and AI Caregivers
VML's latest report outlines key healthcare trends for 2026, emphasizing personalized medicine, AI integration, and trust-building in an era of misinformation.
-
healthEli Lilly’s Orforglipron Wins FDA Approval for Weight Loss
The FDA approved Eli Lilly's once-daily pill for chronic weight management in adults with obesity or related conditions.
-
healthMASLD Drives Rise in Cirrhosis Across Northern Mexico
Metabolic dysfunction-associated steatotic liver disease (MASLD) now leads chronic liver disease in northeastern Mexico, linked to rising obesity and diabetes.
-
healthObesity Drives Advanced Liver Disease-New Treatments Emerge
Obesity is now a leading cause of cirrhosis and liver cancer. Weight loss and GLP-1 drugs show promise in halting progression.
-
healthWeight Loss Drugs Show Greater Efficacy in Women, Study Finds
New meta-analysis reveals GLP-1 receptor agonists significantly outperform in women compared to men, offering key insights for obesity and diabetes treatment.
-
healthKenya's Weight-Loss Boom: Shifting Beauty Standards Drive Medical Procedures
Kenya sees a surge in demand for weight-loss treatments, from drugs like Ozempic to surgical procedures, as societal views on beauty and health evolve.
-
healthAsthma Biologics Underprescribed for Obese Patients Despite Proven Efficacy
New analysis reveals respiratory biologics, crucial for severe asthma, are significantly underused in eligible patients with obesity, impacting exacerbation rates and treatment access.